LSN862
peroxisome proliferator-activated receptor (PPAR)alpha/gamma dual agonist with a unique in vitro profile that shows improvements on glucose and lipid levels in rodent models of type 2 diabetes and dyslipidemia; structure in first source
Networked: 2
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Du, Eric:
1 article
(01/2013)
|
2. | Emborg, Marina E:
1 article
(01/2013)
|
3. | Johnson, Delinda A:
1 article
(01/2013)
|
4. | Johnson, Jeffrey A:
1 article
(01/2013)
|
5. | Swanson, Christine R:
1 article
(01/2013)
|
6. | Barr, Robert:
1 article
(06/2005)
|
7. | Bensch, William R:
1 article
(06/2005)
|
8. | Brozinick, Joseph T:
1 article
(06/2005)
|
9. | Bull, Chris:
1 article
(06/2005)
|
10. | Dana, Sharon:
1 article
(06/2005)
|
Related Diseases
Related Drugs and Biologics